Alcresta's Unattributed VC Round

Alcresta raised a round of funding on September 25, 2017.

Alcresta Therapeutics is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its technology platfor…

Articles about Alcresta's Unattributed VC Round: